PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
International Journal of Surgery10.1016/j.ijsu.2012.06.2052012108S39Survival rates for patients with anaplastic thyroid carcinoma receiving different treatment modalities.Natalie Lowe, Beng Yaphttps://api.elsevier.com/content/article/PII:S1743919112003421?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1743919112003421?httpAccept=text/plain
Journal of Korean Society of Endocrinology10.3803/jkes.2005.20.2.1272005202127The Effect of Treatment Modalities on Survival Rates of Patients with Anaplastic Thyroid CarcinomaJae Myoung Choi, Mi Jeong Kim, Seung Won Lee, Kyoung Eun Song, Yoon-Sok Chung, Kwan Woo Lee, Dae Jung Kim, Sung Hee Choi, So Hun Kim, Min Ho Cho, Yumie Rhee, Chul Woo Ahn, Sung Kil Lim, Kyung Rae Kimhttps://synapse.koreamed.org/DOIx.php?id=10.3803/jkes.2005.20.2.127, https://synapse.koreamed.org/pdf/10.3803/jkes.2005.20.2.127, http://synapse.koreamed.org/DOIx.php?id=10.3803/jkes.2005.20.2.127
Cancer10.1002/cncr.31252201812481780-1790Treatment and survival vary by race/ethnicity in patients with anaplastic thyroid cancerAnsley M. Roche, Stacey A. Fedewa, Lucy L. Shi, Amy Y. Chenhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fcncr.31252, https://onlinelibrary.wiley.com/doi/full/10.1002/cncr.31252
European Journal of Cancer Supplements10.1016/s1359-6349(05)81350-32005323041055 POSTER Multimodality treatment for anaplastic thyroid carcinoma — does it improve survival?https://api.elsevier.com/content/article/PII:S1359634905813503?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1359634905813503?httpAccept=text/plain
European Journal of Surgical Oncology (EJSO)10.1053/ejso.2000.10982001273260-264Effect of primary treatment on survival in anaplastic thyroid carcinomaN. Besic, M. Auersperg, M. Us-Krasovec, R. Golouh, S. Frkovic-Grazio, A. Vodnikhttps://api.elsevier.com/content/article/PII:S0748798300910989?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0748798300910989?httpAccept=text/plain
European Journal of Cancer10.1016/s0959-8049(99)81261-1199935S212Primary treatment and survival in anaplastic thyroid carcinomaN. Bešić, M. Auersperg, M. Us-Krašovec, R. Golouh, E. Breceljhttps://api.elsevier.com/content/article/PII:S0959804999812611?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0959804999812611?httpAccept=text/plain
Thyroid Diseases10.1007/978-3-319-45013-1_232018629-643Anaplastic and Other Forms of Thyroid CarcinomaLeonard Wartofskyhttp://link.springer.com/content/pdf/10.1007/978-3-319-45013-1_23
Advances in Genomics and Genetics10.2147/agg.s53448201543Anaplastic thyroid cancer – an overview of genetic variations and treatment modalitiesHoney Reddi, Anirudh Kumar, Roger Kulstadhttps://www.dovepress.com/getfile.php?fileID=23270
Thyroid10.1089/thy.2000.10.5872000107587-594Treatment of Anaplastic Thyroid Carcinoma with Paclitaxel: Phase 2 Trial Using Ninety-Six-hour InfusionKenneth B. Ain, Merrill J. Egorin, Philip A. DeSimone, https://www.liebertpub.com/doi/pdf/10.1089/thy.2000.10.587
Imaging in Otolaryngology10.1016/b978-0-323-54508-2.50077-72018106Anaplastic Thyroid Carcinomahttps://api.elsevier.com/content/article/PII:B9780323545082500777?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:B9780323545082500777?httpAccept=text/plain